以下部分引用 AI 总结，现阶段 AI 仍然有幻觉。请以内容的原文为准。
数据新鲜度群聊 07-14 ✓卖方 07-14 ✓Wrap 断档15天 ✕News 07-15 ✓X 断档12天 ✕页面生成 07-15
Novartis
8 atoms · 跨 5 天 · 首见 2026-04-28 · 最近 2026-06-11
三色: 🟦 fact 7 · 🟥 take 1 · stance ▲1/▼2/◆5
来源: X 8
时态: fresh:6 · aging:2
标签: 好信源:6 · 好观点:1 · 好数字:1
叙事 (narrative) (2)
- 2026-04-28
[老化中] · CEO warns reality of Trump drug pricing policy will set in over next 18 months
NOVARTIS CEO WARNS REALITY OF TRUMP'S DRUG PRICING POLICY WILL SET IN OVER 'THE NEXT 18 MONTHS'
tags: 好信源 · → daily
value: date=2026-04-28
- 2026-05-08
[老化中] · 全球垄断地位
category-defining global monopolies the US cannot replicate
tags: 好观点 · → daily
事实 (fact) (6)
- 2026-06-11 · del-brx FSHD trial endpoint met
Novartis’ del-brx met key FSHD trial endpoints and is in Phase III with FDA orphan and fast track status.
tags: 好数字 · → daily
value: qty=met · date=Phase III
- 2026-04-28 · CEO 表述优先级
Novartis’s CEO said the priority is an early rollout of Rhapsido in Germany and Japan, according to a media call.
tags: 好信源 · → daily
value: direction=early rollout in Germany and Japan
- 2026-04-28 · Rhapsido MFN pricing coverage status
The CEO of Novartis said the anti-allergy drug Rhapsido will not be completely covered by the MFN pricing policy.
tags: 好信源 · → daily
value: direction=not fully covered
- 2026-04-28 · Q2 patent expiration impact on Entresto
NOVARTIS CFO SAYS ON U.S. PATENT EXPIRATIONS: Q2 IMPACT FOR ENTRESTO WILL BE SIMILAR TO Q1
tags: 好信源 · → daily
value: date=Q2
- 2026-06-04 · safety consistency
NOVARTIS: SAFETY WAS CONSISTENT WITH PRIOR STUDIES
tags: 好信源 · → daily
- 2026-05-21 · 展示ASCO和EHA数据
Novartis showcases fresh ASCO and EHA data supporting progress in RLT innovation and its leadership across prostate cancer, breast cancer, and hematology.
tags: 好信源 · → daily
value: date=2026-05-21
时间轴 (近 20)
- 2026-06-11 ·
fact · del-brx FSHD trial endpoint met · → daily
- 2026-06-04 ·
fact · safety consistency · → daily
- 2026-05-21 ·
fact · 展示ASCO和EHA数据 · → daily
- 2026-05-08 ·
narrative · 全球垄断地位 · → daily
- 2026-04-28 ·
fact · CEO 表述优先级 · → daily
- 2026-04-28 ·
fact · Rhapsido MFN pricing coverage status · → daily
- 2026-04-28 ·
fact · Q2 patent expiration impact on Entresto · → daily
- 2026-04-28 ·
narrative · CEO warns reality of Trump drug pricing policy will set in o · → daily
← 实体目录 · 系统日志